QLT DRC RET IRD 04: A Study of the Efficacy and Safety of QLT091001 in Subjects with Inherited Retinal Disease (IRD) Caused by Mutation in Retinal Pigment Epithelium Protein 65 (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Research Grant
Administered By
Ophthalmology
Awarded By
QLT, Inc.
Start Date
June 28, 2016
End Date
June 27, 2021
Administered By
Ophthalmology
Awarded By
QLT, Inc.
Start Date
June 28, 2016
End Date
June 27, 2021